Adulsa Therapeutics
Berwyn, US · Founded 2020 · Delaware corporation
Founders & leadership
AM
Andrew MorozovNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$525K disclosed across 1 round · 2021
▶$525KraisedOct 2021 · 2 investors · Biotechnology
▶$525KraisedOct 2021 · 2 investors · Biotechnology
Officers, directors & promoters on the filing
- Andrew MorozovExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $525K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Adulsa Therapeutics raised?
- Adulsa Therapeutics has disclosed $525K raised across 1 round.
- Where is Adulsa Therapeutics headquartered?
- Adulsa Therapeutics is headquartered in Berwyn, US.